Work

Appetite suppressants as adjuncts for weight loss.

Year: 2011

Type: article

Abstract: Phentermine and diethylpropion are appetite suppressants approved for use in the United States as adjuncts in the treatment of obesity. These agents demonstrate a modest weight loss benefit when combined with dietary modifications and exercise. (Strength of Recommendation: B, based on a randomized trial and a meta-analysis.) No current evidence is available on the long-term risks and benefits of these medications, or the most appropriate time to initiate appetite suppressant therapy as part of a comprehensive weight management program.

Source: PubMed

Authors: Blair Wilbert, Brice Labruzzo Mohundro, Vincent Shaw, Amy Andres

Institutions: Baton Rouge General, University of Louisiana at Monroe

Language: English

Topic: Pharmacology and Obesity Treatment

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2284868725

FWCI:

Cites:

Cited by: 8

Related to: 10